In 2023, Denmark led European production of medicaments containing corticosteroid hormones, with a value of 8.3993 billion Euros, experiencing a 16.48% year-on-year growth rate. Other significant changes included the Netherlands, which showed a strong increase of 63.0%, and Germany with 8.63%. In contrast, Italy experienced a notable decline of 21.43%. The highest five-year compound annual growth rate (CAGR) was seen in Denmark, highlighting its growing dominance in this sector. France, although a major player, saw a slight decline. Meanwhile, Poland registered the most significant drop, at -14.65%.
Future trends to watch include increasing demand for corticosteroid hormones driven by Europe's aging population, advances in drug delivery systems, and the potential impact of regulatory changes on market dynamics. Additionally, green and sustainable production methods might become a focal point as environmental concerns continue to rise.
Top countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale by Country
| # | 10 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Denmark | 8,399,300,000 | 2023 | +10.36% | +16.48% | View data |
| 2 | 2 Belgium | 2,321,200,000 | 2023 | +3.18% | +3.69% | View data |
| 3 | 3 Germany | 1,102,100,000 | 2023 | +2.38% | +8.63% | View data |
| 4 | 4 Netherlands | 786,660,000 | 2023 | +37.82% | +63% | View data |
| 5 | 5 France | 535,410,000 | 2023 | -2.71% | -3.06% | View data |
| 6 | 6 Italy | 435,670,000 | 2023 | -2.55% | -21.43% | View data |
| 7 | 7 Spain | 320,000,000 | 2023 | +10.35% | +12.66% | View data |
| 8 | 8 Hungary | 110,550,000 | 2023 | +3.16% | +8.43% | View data |
| 9 | 9 Croatia | 102,690,000 | 2023 | +4.75% | +5.55% | View data |
| 10 | 10 Greece | 26,653,000 | 2023 | +5.99% | +6.44% | View data |
